我们推荐在您的浏览器上开启Javascript，以获得最佳效果。

PLAU 抗体 (N-Term)

Name: PLAU 抗体 (N-Term)
SKU: ABIN1882148
Availability: OutOfStock

Cited in 8+ publications. This anti-PLAU antibody is a 兔多克隆 antibody detecting PLAU in WB, FACS 和 IHC (p). Suitable for 人和小鼠.

Western blot analysis of anti-PLAU Antibody (N-term) (ABIN1882148 and ABIN2842233) in mouse brain tissue lysates (35 μg/lane). (PLAU 抗体 (N-Term))

Formalin-fixed and paraffin-embedded human prostata carcinoma tissue reacted with PLAU antibody (N-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. (PLAU 抗体 (N-Term))

IHC (p)

Western blot analysis of anti-PLAU Antibody (N-term) (ABIN1882148 and ABIN2842233) in cell line lysates (35 μg/lane). (PLAU 抗体 (N-Term))

Urokinase (PLAU) Antibody (N-term) (ABIN1882148 and ABIN2842233) flow cytometric analysis of cells (right histogram) compared to a negative control cell (left histogram). (PLAU 抗体 (N-Term))

FACS

4 images

(8 references)

产品编号 ABIN1882148

发货至: 中国

Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111

No. 88 KeChuang 6th Street

Beijing Economic Technological Development Area

Room 801-803

4A Biotech Co.,Ltd.

Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for PLAU 抗体 (N-Term) (ABIN1882148)

抗原

See all PLAU 抗体

PLAU (Plasminogen Activator, Urokinase (PLAU))

适用

人, 小鼠

宿主

兔

克隆类型

多克隆

标记

This PLAU antibody is un-conjugated

应用范围

Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

克隆位点

RB04087

抗原表位
6

6

6

3

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1
AA 60-90, N-Term

纯化方法

This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.

免疫原

This Urokinase (PLAU) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 60-90 amino acids from the N-terminal region of human Urokinase (PLAU).

亚型

Ig Fraction
anti-Plasminogen Activator, Urokinase (PLAU) (C-Term) antibody
Verified PLAU 适用: 人 ELISA, IHC 宿主: 山羊 Polyclonal unconjugated

anti-Plasminogen Activator, Urokinase (PLAU) (AA 396-426) antibody
PLAU 适用: 人 WB, ELISA, IHC, FACS, IF 宿主: 兔 Polyclonal unconjugated

anti-Plasminogen Activator, Urokinase (PLAU) (AA 60-90) antibody
PLAU 适用: 人, 小鼠 WB, ELISA, IHC, FACS 宿主: 兔 Polyclonal unconjugated

anti-Plasminogen Activator, Urokinase (PLAU) (AA 180-433) antibody
PLAU 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated

anti-Plasminogen Activator, Urokinase (PLAU) (AA 16-115) antibody
PLAU 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 3B8 unconjugated

anti-Plasminogen Activator, Urokinase (PLAU) antibody
PLAU 适用: 人 WB, IHC (p) 宿主: 兔 Polyclonal unconjugated

anti-Plasminogen Activator, Urokinase (PLAU) (AA 396-426), (C-Term) antibody
PLAU 适用: 人 WB, FACS, IHC (p), IF 宿主: 兔 Polyclonal RB04089-04090 unconjugated

anti-Plasminogen Activator, Urokinase (PLAU) (AA 17-432) antibody
PLAU 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated

anti-Plasminogen Activator, Urokinase (PLAU) (AA 20-180) antibody
PLAU 适用: 人 WB 宿主: 兔 Polyclonal unconjugated

anti-Plasminogen Activator, Urokinase (PLAU) (AA 21-173) antibody
PLAU 适用: 人 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated

应用备注

WB: 1:1000. WB: 1:1000. IHC-P: 1:10~50. FC: 1:10~50

限制

仅限研究用
状态

Liquid

缓冲液

Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

储存液

Sodium azide

注意事项

This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

储存条件

4 °C,-20 °C

有效期

6 months
Kim, Minai-Tehrani, Kim, Shin, Hong, Kim, Lee, Chang, Yu, Bang, Cho, Yoon, Yu, Jiang, Cho: "Suppression of tumor growth in H-ras12V liver cancer mice by delivery of programmed cell death protein 4 using galactosylated poly(ethylene glycol)-chitosan-graft-spermine." in: Biomaterials, Vol. 33, Issue 6, pp. 1894-902, (2011) (PubMed).

Eefting, de Vries, Grimbergen, Karper, van Bockel, Quax et al.: "In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase ..." in: Journal of vascular surgery, Vol. 51, Issue 2, pp. 429-37, (2010) (PubMed).

Bacac, Migliavacca, Stehle, McKee, Delorenzi, Coindre, Guillou, Stamenkovic: "A gene expression signature that distinguishes desmoid tumours from nodular fasciitis." in: The Journal of pathology, Vol. 208, Issue 4, pp. 543-53, (2006) (PubMed).

Strausberg, Feingold, Grouse, Derge, Klausner, Collins, Wagner, Shenmen, Schuler, Altschul, Zeeberg, Buetow, Schaefer, Bhat, Hopkins, Jordan, Moore, Max, Wang, Hsieh, Diatchenko, Marusina, Farmer et al.: "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. ..." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Issue 26, pp. 16899-903, (2002) (PubMed).

Sperl, Jacob, Arroyo de Prada, Stürzebecher, Wilhelm, Bode, Magdolen, Huber, Moroder: "(4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, Issue 10, pp. 5113-8, (2000) (PubMed).

Türkmen, Schmitt, Schmalfeldt, Trommler, Hell, Creutzburg, Graeff, Magdolen: "Mutational analysis of the genes encoding urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer." in: Electrophoresis, Vol. 18, Issue 5, pp. 686-9, (1997) (PubMed).

Conne, Berczy, Belin: "Detection of polymorphisms in the human urokinase-type plasminogen activator gene." in: Thrombosis and haemostasis, Vol. 77, Issue 3, pp. 434-5, (1997) (PubMed).

Yoshimoto, Ushiyama, Sakai, Tamaki, Hara, Takahashi, Sawasaki, Hanada: "Characterization of single chain urokinase-type plasminogen activator with a novel amino-acid substitution in the kringle structure." in: Biochimica et biophysica acta, Vol. 1293, Issue 1, pp. 83-9, (1996) (PubMed).
抗原

PLAU (Plasminogen Activator, Urokinase (PLAU))

背景

PLAU, a member of the peptidase family S1, is a potent plasminogen activator and is clinically used for therapy of thrombolytic disorders. PLAU specifically cleaves the Arg-|-Val bond in plasminogen to form plasmin. The protein is found in high and low molecular mass forms. Each consists of two chains, A and B. The high molecular mass form contains a long chain A. Cleavage occurs after residue 155 in the low molecular mass form to yield a short A1 chain. The protein is used in Pulmonary Embolism (PE) to initiates fibrinolysis. Structurally, PLAU contains 1 EGF-like domain and 1 kringle domain.

分子量

48507

NCBI登录号

NP_001138503, NP_002649

UniProt

P00749

途径

Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagy, Smooth Muscle Cell Migration